1. Home
  2. BGLC vs DRCT Comparison

BGLC vs DRCT Comparison

Compare BGLC & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$3.95

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.06

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
DRCT
Founded
2017
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BGLC
DRCT
Price
$3.95
$0.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
22.6K
25.1M
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,465,006.00
$35,369,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.40
P/E Ratio
N/A
N/A
Revenue Growth
2.21
N/A
52 Week Low
$2.01
$0.05
52 Week High
$15.60
$2.61

Technical Indicators

Market Signals
Indicator
BGLC
DRCT
Relative Strength Index (RSI) 33.82 28.86
Support Level $3.98 $0.05
Resistance Level $4.04 $0.08
Average True Range (ATR) 0.13 0.01
MACD 0.01 0.01
Stochastic Oscillator 14.97 22.36

Price Performance

Historical Comparison
BGLC
DRCT

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

Share on Social Networks: